𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pergolide effective in early Parkinson’s disease

Book ID
120872353
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
1999
Weight
244 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pergolide therapy in parkinson's disease
Pergolide therapy in parkinson's disease
✍ P. Jeanty; M. Kerchove; A. Lowenthal; H. Bruyne 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 543 KB

A total of 26 patients were treated with pergolide mesylate, a semi-synthetic ergot derivative with the property of direct dopamine activity. Of these patients, 18 suffered from late failure of L-dopa, while the remaining 8 had never before been treated with L-dopa. The aim of the trial was to study

Pergolide versus levodopa monotherapy in
Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study
✍ Wolfgang H. Oertel; Erik Wolters; Cristina Sampaio; Santiago Gimenez-Roldan; Bru 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

## Abstract Dopamine agonists are used as initial treatment in patients with Parkinson's disease (PD) to reduce incidence and severity of motor complications. This paradigm is based on long‐term studies, allowing “rescue” therapy with levodopa. The present strict monotherapy study (PELMOPET, the ac